SCHEMBL8790264

SCHEMBL8790264

Cc1ccc(-c2nnnn2CC(=O)O)s1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.55
HPGD P15428 1/20 0.55
KDM4C Q9H3R0 1/20 0.43
LMNA P02545 2/20 0.38
KMT2A Q03164 2/20 0.38
HSD11B1 P28845 2/20 0.37
GRIN1 Q05586 1/20 0.36
GRIN2B Q13224 1/20 0.36
DAO P14920 1/20 0.36
HDAC3 O15379 1/20 0.36
CYP3A4 P08684 1/20 0.36
HDAC4 P56524 1/20 0.36
HDAC1 Q13547 1/20 0.36
HDAC7 Q8WUI4 1/20 0.36
HDAC2 Q92769 1/20 0.36
HDAC10 Q969S8 1/20 0.36
HDAC11 Q96DB2 1/20 0.36
HDAC8 Q9BY41 1/20 0.36
HDAC6 Q9UBN7 1/20 0.36
HDAC9 Q9UKV0 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8790035 0.86 ALDH1A1 (0.50) ALDH1A1HPGDKDM4CLMNAKMT2A
SCHEMBL8790795 0.85 ALDH1A1 (0.52) ALDH1A1HPGDKDM4CLMNAKMT2A
SCHEMBL8791041 0.85 ALDH1A1 (0.49) ALDH1A1HPGDKDM4CLMNAKMT2A
SCHEMBL8792333 0.84 ALDH1A1 (0.55) ALDH1A1HPGDKDM4CKMT2AHSD11B1
SCHEMBL9845581 0.83 ALDH1A1 (0.47) ALDH1A1HPGDKDM4CKMT2AHSD11B1
SCHEMBL8791092 0.82 ALDH1A1 (0.46) ALDH1A1HPGDKDM4CPOLBTDP1
SCHEMBL8791245 0.80 ALDH1A1 (0.47) ALDH1A1HPGDKDM4CKMT2AHSD11B1
SCHEMBL8790845 0.79 ALDH1A1 (0.46) ALDH1A1HPGDKDM4CKMT2AHSD11B1
SCHEMBL8791772 0.79 KDM4E (0.48) ALDH1A1HPGDKDM4CKMT2AHDAC3
SCHEMBL8792673 0.79 ALDH1A1 (0.43) ALDH1A1HPGDKDM4CLMNAKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0421365-B1 Tetrazoleacetic acid derivatives having aldose reductase inhibitory activity WAKAMOTO PHARMA CO LTD (JP) 1997-03-05 EP disclosed
US-RE35321-E ANTIDIABETIC AGENT WAKAMOTO PHARMACEUTICAL CO., LTD. (JP) 1996-08-27 US disclosed
US-5068239-A Antidiabetic agent WAKAMOTO PHARMACEUTICAL CO., LTD. (JP) 1991-11-26 US disclosed
EP-0421365-A2 Tetrazoleacetic acid derivatives having aldose reductase inhibitory activity Wakamoto Pharmaceutical Co., Ltd. (JP) 1991-04-10 EP disclosed